ENTPD1 and sarcoidosis: Moreover, we found that the level of CD39-expressing Tregs (Figure 4A) was increased in patients with sarcoidosis in comparison with the control group (53.03% (37.46; 60.22) vs. 40.16% (17.67; 52.30) with p < 0.01).